A Phase I Clinical Trial to Assess the Safety and Immunogenicity of DX-104

Clinical trial NCT07395739 · RECRUITING

Trial details

NCT number: NCT07395739
Sponsor: Shanghai Yuguan Biotech Co., Ltd.（Delonix Bioworks)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Neisseria Meningitidis Serogroup B

Start date: 2026-03-20
Primary completion: 2027-05-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.